Reversal of aqueous flow in myopic, vitrectomized eyes with scleral-fixated intraocular lenses: A proposed mechanism underlying reverse pupillary block
Publication date: December 2026 Source: American Journal of Ophthalmology Case Reports, Volume 44 Author(s): Steven G. Safran, Brian M. Smith, Minas T. Coroneo
Reversal of aqueous flow in myopic, vitrectomized eyes with scleral-fixated intraocular lenses: A proposed mechanism underlying reverse pupillary block. // American Journal of Ophthalmology Case Reports. – URL: https://www.sciencedirect.com/science/article/pii/S2451993626001416?dgcid=rss_sd_all
Reversal of aqueous flow in myopic, vitrectomized eyes with scleral-fixated intraocular lenses: A proposed mechanism underlying reverse pupillary block. American Journal of Ophthalmology Case Reports. https://www.sciencedirect.com/science/article/pii/S2451993626001416?dgcid=rss_sd_all
“Reversal of aqueous flow in myopic, vitrectomized eyes with scleral-fixated intraocular lenses: A proposed mechanism underlying reverse pupillary block.” American Journal of Ophthalmology Case Reports.
@article{article88321,
title = {Reversal of aqueous flow in myopic, vitrectomized eyes with scleral-fixated intraocular lenses: A proposed mechanism underlying reverse pupillary block},
journal = {American Journal of Ophthalmology Case Reports},
url = {https://www.sciencedirect.com/science/article/pii/S2451993626001416?dgcid=rss_sd_all}
}
Abstract Purpose To compare the efficacy of intravitreal dexamethasone (DEX) implant‐based regimen versus ranibizumab‐based regimen for managing retinal exudation and complications in stage 3 Coats' disease. Methods Thirty‐seven eyes...
Abstract Foundation models are rapidly emerging as a major development in ophthalmic artificial intelligence, largely because they can achieve strong downstream performance with fewer labelled images than conventional supervised models,...
Abstract Purpose To evaluate intraretinal fluid (IRF) volume dynamics after switching from aflibercept 2 mg to faricimab in eyes with diabetic macular oedema (DME), stratified by prior response to aflibercept. Methods This retrospective...